Project Grant R21HD117154

Award Date 9/19/24
Completion Date 8/31/26
Dollars Obligated $451K
Federal Grant Program
93.865
Assistance Type
Project Grant
Place of Performance
Dallas, TX 75390, USA
Similar Awards
This federal Project Grant award from the National Institute of Child Health and Human Development (NICHD), under CFDA program 93.865 Child Health and Human Development Extramural Research, supports research to resolve the mechanism of osteoclast multinucleation and signaling in bone remodeling. The $249,000 award, effective September 1, 2024 through August 31, 2027, will fund the University of Virginia's research to: Identify the lupus La protein domain that regulates osteoclast...
This federal Project Grant award of $1,204,928 from the National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research program (CFDA 93.865), supports research to investigate the mechanisms by which rare genetic variants in regulatory enhancer regions can cause ectopic gene expression and developmental disorders, using limb malformations as a model. The key objectives of the award are to: 1) characterize the chromatin and...
This $1,633,451 federal Project Grant award from the National Institutes of Health (NIH) Trans-NIH Research Support program (CFDA 93.310) will fund a research project at Texas A&M AgriLife Research to determine the cell-specific mechanisms driving aberrant bone regeneration in Down syndrome. The 3-year project aims to characterize the transcriptome, osteoclast/osteoblast activity, and sexually dimorphic impacts on bone healing in multiple murine models of Down syndrome. The research will...
This $995,880 federal Project Grant awarded by the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research Program (CFDA 93.865) will support a multi-disciplinary research project investigating a novel molecular pathway that links protein N-glycosylation in the endoplasmic reticulum to Wnt signaling and regulation of human development. The project aims to delineate the components and mechanisms of this N-glycosylation...
This $499,055.48 federal Project Grant award from the National Institute of Child Health and Human Development (CFDA 93.865 - Child Health and Human Development Extramural Research) supports research to identify novel noncoding mechanisms of disease associated with developmental disorders (DDs). The key objectives are to: (1) define novel candidate long-range positional effect loci by identifying topologically associated domains (TADs) intolerant to disruption and building models to predict...
The University of Texas Southwestern Medical Center was awarded a $264,600 project grant by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program. The project aims to elucidate the mechanisms underlying CBX1-related syndrome, a neurodevelopmental disorder caused by variants in the CBX1 gene that encodes heterochromatin protein 1 beta (HP1B). The research will...
This Project Grant award from the National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research program (CFDA 93.865), provides $216,850 to the University of California, Los Angeles (UCLA) for a research project titled "Genetic Determinants of Endoplasmic Reticulum Stress in OI and Its Consequences on Cellular Receptors." The research aims to investigate the genotype-dependent accumulation of misfolded type I collagen...
This federal Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846) provides $147,656 in funding to The Children's Hospital of Philadelphia Research Institute to conduct research on skeletal patterning and growth plate chondrocyte regulation. The research aims to thoroughly define the skeletal phenotypes of mice with inactivated Runx2 and Runx3 genes, identify...
The National Institute of Child Health and Human Development (NICHD) awarded a $350,604 Project Grant (CFDA 93.865 - Child Health and Human Development Extramural Research) to The Trustees of the University of Pennsylvania, doing business as Clinical Practices of the University of Pennsylvania, on August 10, 2024. The grant supports a research project titled "Molecular Basis for BMP Receptor Specialization and Trafficking" that aims to determine the specialized roles of different...
This federal Project Grant award from the National Institute of Child Health and Human Development (CFDA 93.865 Child Health and Human Development Extramural Research) provides $419,204 to The University of Kentucky Research Foundation to conduct a research project titled "Functional Characterization of Genetic Variants in Rare Disease Associated with SHOC2 Scaffold". The research aims to use a zebrafish vertebrate model to gain insights into the molecular and cellular processes...

This federal Project Grant award from the National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research program (CFDA 93.865), provides $451,000.00 in funding to The University of Texas Southwestern Medical Center (UT Southwestern) to elucidate the molecular mechanism of the KBTBD2 protein in bone development and its role in the pathogenesis of Short Syndrome.

The research aims to investigate the intrinsic role of KBTBD2 in regulating osteogenesis by targeting the P85A regulatory subunit of PI3K, a key node in the IGF-1 signaling pathway. It will also explore how the P85A R649W mutation disrupts its interaction with KBTBD2, leading to decreased ubiquitination and degradation, potentially causing the Short Syndrome disorder. The award period is from September 19, 2024 to August 31, 2026, with the goal of providing a comprehensive understanding of KBTBD2's role in skeletal development and yielding new therapeutic strategies for treating childhood growth disorders.

Generated 4/29/25, 4:07 AM